G-7 Works to Secure Critical Minerals in Face of China Curbs
The Group of Seven leading economies are working to shore up supplies of critical minerals as they seek to move away from reliance on China for materials used in everything from mobile phones to wind turbines.
G-7 leaders aim to agree to a statement at their meeting in Kananaskis, Canada, to establish an 'action plan' to diversify supplies of the vital metals and encourage 'immediate and scaled investment' in projects, according to a draft document obtained by Bloomberg. Without mentioning China — which accounts for almost 70% of the world's production of rare earths — they mentioned the 'threat to our economies' of current practices in the sector.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
28 minutes ago
- Hamilton Spectator
Whitehorse churchgoers in Calgary to call on G7 leaders for debt cancellation
Two parishioners from Whitehorse United Church are in Calgary for the G7 Jubilee People's Forum. Stéphanie Nobécourt and Marie-Alexis Dangréau are attending the forum, which is scheduled to take place between June 12 to 15 — ahead of the G7 Leaders' Summit, which will see the leaders of Japan, the United States, Italy, the European Union, France, Germany, and the U.K. converge on Kananaskis, Alberta. KAIROS Canada — a faith-based organization associated with the United Church of Canada — is hosting the forum. The forum will see activists from across Canada call upon the leaders attending the G7 to cancel the debts of the world's poorest countries. The name of the forum is rooted in the religious tradition of jubilee, in which debts are cancelled, slaves are freed, and the land is permitted to rest without farming, said Nobécourt. The Roman Catholic Church declared 2025 to be a jubilee year: previous jubilee years include 2016 and 2000. In 2000, according to KAIROS, $100 billion of debt was cancelled for 35 nations. 'Today, there's about 3.3 billion people — so it's about 40 per cent of the world's population —that are facing, that are living in countries that are facing a debt crisis,' said Nobécourt, speaking to the News from Calgary. 'They spend more money on reimbursing the interest, reimbursing the debt, rather than spending money on their health and social and educational project,' she said. 'In some cases, it's really recognized that there is no way they can get out of it.' According to United Nations Trade and Development , developing countries are sinking deeper into a debt crisis. The agency said developing nations face higher interest rates than developed countries. In 2023, 54 countries — almost half of which are in Africa — spent at least 10 per cent of government funds on interest payments. In Calgary, Nobécourt and Dangréau said they will spend their time in workshops, so they can bring back what they learned to Whitehorse. They also said that they will be attending a march on June 15 — the start of the G7 summit. Nobécourt said this year's jubilee is calling not only for debt cancellation, but also global financial reform and the creation of a transparent, binding and fair debt resolution framework with the United Nations. Dangréau said that the debt in question goes beyond simply financial debt but also ecological debt. 'Wealthy countries like Canada, they don't just, you know, lend money to this country. They also exploit resources from these already heavily indebted countries and also from Indigenous communities. And all of that exploitation is causing harm, human rights violations and severe ecological harm to this country,' she said. The heap leach facility failure at Victoria Gold's Eagle Mine in 2024 is one example that Nobécourt lists as ecological debt that may hit close to home. 'We impact the land, and we impact all the beings that live on this land. And we impact also Indigenous people that live off this land, not only for eating, but also spiritually, for their practice and their relationship with the land,' she said. For Nobécourt, being in Calgary for the forum reflects with her values. 'It's such a great opportunity to put my values in action, to voice concerns about our society and what should be integrated in our evolving structure,' said Nobécourt. 'Whatever we are creating as a society is not something that is set in stone, can always evolve. We are aware of mistakes we are doing. And it's a way for me to voice it.' Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Yahoo
30 minutes ago
- Yahoo
Asian Stocks Estimated Below Intrinsic Value In June 2025
Amidst escalating geopolitical tensions in the Middle East and ongoing trade discussions, Asian markets have been navigating a complex landscape, with mixed performances across major indices. As investors seek opportunities in this environment, identifying stocks that are potentially undervalued relative to their intrinsic value can be a strategic approach to capitalizing on market fluctuations. Name Current Price Fair Value (Est) Discount (Est) Taiwan Union Technology (TPEX:6274) NT$216.50 NT$424.21 49% StemCell Institute (TSE:7096) ¥1070.00 ¥2118.09 49.5% Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥21.98 CN¥43.55 49.5% PixArt Imaging (TPEX:3227) NT$219.50 NT$436.51 49.7% Peijia Medical (SEHK:9996) HK$6.43 HK$12.71 49.4% Livero (TSE:9245) ¥1719.00 ¥3376.98 49.1% Good Will Instrument (TWSE:2423) NT$43.90 NT$87.32 49.7% Food & Life Companies (TSE:3563) ¥6579.00 ¥12942.09 49.2% Dive (TSE:151A) ¥917.00 ¥1832.47 50% cottaLTD (TSE:3359) ¥442.00 ¥866.08 49% Click here to see the full list of 292 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Overview: S&D Co., Ltd, with a market cap of ₩397.75 billion, develops and sells health functional food in South Korea. Operations: Revenue Segments (in millions of ₩): Estimated Discount To Fair Value: 23.1% S&D Co., Ltd is trading at ₩137,500, which is 23.1% below its estimated fair value of ₩178,875.67, indicating it may be undervalued based on cash flows. The company's earnings are forecast to grow significantly at 23.4% annually, outpacing the Korean market's average growth rate of 21%. Revenue growth is also expected to exceed market averages at 20.9% per year. However, recent share price volatility could pose risks for investors seeking stability. The analysis detailed in our S&D growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in S&D's balance sheet health report. Overview: DPC Dash Ltd, along with its subsidiaries, runs a chain of fast-food restaurants in the People's Republic of China and has a market cap of HK$12.92 billion. Operations: The company generates revenue primarily from its chain of fast-food restaurants in the People's Republic of China, totaling CN¥4.31 billion. Estimated Discount To Fair Value: 17.9% DPC Dash Ltd, trading at HK$98.7, is priced 17.9% below its fair value estimate of HK$120.2, reflecting potential undervaluation based on cash flows. The company recently turned profitable with net income of CNY 55.2 million and expects earnings to grow significantly at 51.3% annually, surpassing the Hong Kong market's growth rate of 10.6%. However, significant insider selling over the past quarter could be a concern for investors evaluating stability and confidence in future performance. Our growth report here indicates DPC Dash may be poised for an improving outlook. Click here and access our complete balance sheet health report to understand the dynamics of DPC Dash. Overview: Peijia Medical Limited, with a market cap of HK$4.28 billion, focuses on the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. Operations: Peijia Medical generates revenue from its Neurointerventional Business, which accounts for CN¥355.55 million, and its Transcatheter Valve Therapeutic Business, contributing CN¥259.94 million. Estimated Discount To Fair Value: 49.4% Peijia Medical, trading at HK$6.43, is significantly undervalued based on cash flows with a fair value estimate of HK$12.71. Despite reporting a net loss of CNY 226.58 million in 2024, the company is expected to become profitable within three years and outpace market growth with projected revenue increases of 27.9% annually. Recent advancements include regulatory acceptance for innovative medical devices and successful clinical trials, potentially enhancing future revenue streams and investor confidence. Upon reviewing our latest growth report, Peijia Medical's projected financial performance appears quite optimistic. Take a closer look at Peijia Medical's balance sheet health here in our report. Delve into our full catalog of 292 Undervalued Asian Stocks Based On Cash Flows here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A260970 SEHK:1405 and SEHK:9996. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
30 minutes ago
- Yahoo
Nepra Foods Announces Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BRITISH COLUMBIA / / June 16, 2025 / Nepra Foods Inc. (CSE:NPRA)(FSE:2P6)(OTCQB:NPRFF) ("Nepra Foods" or the "Company") is pleased to announce a non-brokered private placement of up to 8,333,333 units of the Company (the "Units") at a price of US$0.06 per Unit for gross proceeds of up to US$500,000 (the "Offering"). Each Unit will consist of one common share in the capital of the Company (a "Share") and one Share purchase warrant (a "Warrant"). Each Warrant will entitle the holder thereof to purchase one additional Share (a "Warrant Share") at an exercise price of US$0.12 per Warrant Share for a period of 24 months following issuance. The Company may pay finder's fees on the Offering within the amount permitted by the policies of the Canadian Securities Exchange (the "CSE"). The Company will use the proceeds from the Offering for general working capital purposes. Closing of the Offering is subject to certain conditions, including receipt of all necessary corporate and regulatory approvals, including the CSE. All securities issued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation and will be issued as "restricted securities" as defined in Rule 144(a)(3) under the United States Securities Act of 1933, as amended (the "1933 Act"). The Offering is not subject to a minimum aggregate amount of subscriptions. The Shares, Warrants and Warrant Shares underlying the Warrants (collectively, the "Securities") being offered have not been, nor will they be, registered under the1933 Act, or any state securities laws, and may not be offered or sold in the United States or to, of for the account or benefit of, "U.S. persons" (as defined in Regulation S under the 1933 Act) absent registration or an applicable exemption from the registration requirements of the 1933 Act and applicable state securities laws. This press release will not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. About Nepra Foods Nepra Foods is a specialty food company focused on innovative and proprietary allergen and gluten-free food ingredient technologies. The company supports food manufacturers globally with formulations, ingredients and technical support for the production of the next generation of healthy, nutritious foods. For more information on the company, visit ON BEHALF OF THE BOARD OF DIRECTORS William Hogan, CEO & Director investors@ The CSE has neither approved nor disapproved the contents of this news release. The CSE does not accept responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains statements and information that, to the extent that they are not historical fact, constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information is based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, but not limited to, statements relating to the Company's financial performance, business development, results of operations, and those listed in filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all of such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking information to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. SOURCE: Nepra Foods Inc. View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
